Phenotype alteration in colon carcinoma cells: effect of in vivo passage?
- PMID: 1649163
- DOI: 10.1007/BF02630955
Phenotype alteration in colon carcinoma cells: effect of in vivo passage?
Abstract
A panel of rat colon adenocarcinoma cell lines (the Per series) were used to investigate the phenotype and karyotype changes induced by in vivo passage in the subcutis of athymic nude mice. One poorly and one well-differentiated tumor cell line were serially passaged through the athymic nude mouse and then back to the syngeneic rat host. Each of the primary and xenograft cell lines expressed fetal crypt cell ("CaCo") antigens. The well differentiated primary and xenograft lines (Per305, Per305N1, and Per305N2a) were different in each of their growth factor responsiveness in vitro [i.e. epidermal growth factor (EGF), bombesin, vasoactive intestinal peptide], their EGF receptor expression, their secretion of transforming growth factor-alpha, and their exhibition of anchorage independent (A-I) growth capabilities. The poorly differentiated primary and xenograft cell lines were also different but were all capable of A-I growth; their responsiveness to exogenous growth factor stimulation decreased with progressive in vivo passage, as did their basal unstimulated proliferation rate. Cytogenetic alterations detected were those associated with clinical specimens from various stages of malignancy, i. e. aneuploidy, structural aberrations, and marker chromosomes. Genetic and mitogenic individuality of each line demonstrated the diversity of the growth control mechanisms in neoplasms at different stages of progression.
Similar articles
-
Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):956-60. doi: 10.1073/pnas.94.3.956. Proc Natl Acad Sci U S A. 1997. PMID: 9023364 Free PMC article.
-
Autonomous proliferation of colon cancer cells that coexpress transforming growth factor alpha and its receptor. Variable effects of receptor-blocking antibody.Gastroenterology. 1992 Feb;102(2):474-85. doi: 10.1016/0016-5085(92)90093-e. Gastroenterology. 1992. PMID: 1732118
-
Establishment and characterization of a human gastric scirrhous carcinoma cell line in serum-free chemically defined medium.Int J Cancer. 1993 May 8;54(2):200-7. doi: 10.1002/ijc.2910540207. Int J Cancer. 1993. PMID: 8387462
-
Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.Cell Growth Differ. 1992 Nov;3(11):819-25. Cell Growth Differ. 1992. PMID: 1467309
-
Heterogeneity of human colon carcinoma.Cancer Metastasis Rev. 1984;3(3):177-91. doi: 10.1007/BF00048384. Cancer Metastasis Rev. 1984. PMID: 6437669 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials